Position in SNY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$294,780
-$32,362 QoQ
Shares Held
6,910
+1.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#419
of 712 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SNY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cetera Trust Company, N.A holds $8,988,212 across 12 Drug Manufacturers - General names. SNY ranks #8 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
8,983 | $3,252,923 | |
| 2 | LLY |
ELI LILLY & Co
|
2,087 | $2,503,210 | |
| 3 | MRK |
Merck & Co., Inc.
|
7,054 | $906,439 | |
| 4 | NVS |
Novartis AG
|
3,252 | $509,653 | |
| 5 | AZN |
Astrazeneca PLC
|
2,369 | $449,209 | |
| 6 | JNJ |
Johnson & Johnson
|
1,694 | $430,225 | |
| 7 | GSK |
GSK plc
|
7,905 | $414,380 | |
| 8 | SNY |
Sanofi
This page
|
6,910 | $294,780 |
All Filings in SNY
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $294,780 | 6,910 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $327,142 | 6,790 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $329,043 | 6,790 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $289,808 | 6,140 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $296,623 | 6,140 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $326,659 | 5,890 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $284,074 | 5,890 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $330,796 | 5,740 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $278,504 | 5,740 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $278,964 | 5,740 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $300,369 | 6,040 | Shares | Sole | 2024-02-01 | |
| No filing history on record for this holder in this stock. | ||||||